Acyl bromides
![eMolecules 7699-45-8 | Zinc bromide | Oakwood Chemicals | MFCD00011294 | 225.190 | Br2Zn | 98.000 | [Zn++].[Br-].[Br-] | 100g | 480169583](https://assets.fishersci.com/TFS-Assets/CCG/product-images/default.jpg-250.jpg)
eMolecules 7699-45-8 | Zinc bromide | Oakwood Chemicals | MFCD00011294 | 225.190 | Br2Zn | 98.000 | [Zn++].[Br-].[Br-] | 100g | 480169583
Zinc bromide | Oakwood Chemicals | 7699-45-8 | MFCD00011294 | 225.190 | Br2Zn | 98.000 | [Zn++].[Br-].[Br-] | 100g | 480169583
![eMolecules 7699-45-8 | Zinc bromide | Oakwood Chemicals | MFCD00011294 | 225.190 | Br2Zn | 98.000 | [Zn++].[Br-].[Br-] | 25g | 480169582](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000165587.jpg-250.jpg)
eMolecules 7699-45-8 | Zinc bromide | Oakwood Chemicals | MFCD00011294 | 225.190 | Br2Zn | 98.000 | [Zn++].[Br-].[Br-] | 25g | 480169582
Zinc bromide | Oakwood Chemicals | 7699-45-8 | MFCD00011294 | 225.190 | Br2Zn | 98.000 | [Zn++].[Br-].[Br-] | 25g | 480169582
Medchemexpress LLC Pinaverium bromide | 53251-94-8 | 99.7% | 591.42 | 25 MG
Pinaverium bromide | 53251-94-8 | 99.7% | 591.42 | 25 MG
Medchemexpress LLC Demecarium bromide | 56-94-0 | 95.0% | 1 ML
Demecarium Bromide (BC-48) is a potent cholinesterase inhibitor known for its apparent affinity (Kiapp) of 0.15 μM. It serves as a glaucoma agent, effective in both normotensive and inherited glaucoma conditions. In vivo studies demonstrate its ability to cause long-term miosis and decrease intraocular pressure.
- Potent cholinesterase inhibitor
- Apparent affinity (Kiapp) of 0.15 μM
- Used as a glaucoma agent
- Causes long-term miosis
- Decreases intraocular pressure (IOP)
Medchemexpress LLC Valethamate (bromide) | 90-22-2 | 99.3% | 1 ML
Valethamate bromide is an ester that acts as an effective, rapidly acting anticholinergic antispasmodic and muscle relaxant. It accelerates labor by improving cervical dilation, significantly shortening the labor process with fewer side effects.
- Acts as an effective, rapidly acting anticholinergic antispasmodic and muscle relaxant
- Accelerates labor by improving cervical dilation
- Significantly shortens the labor process with fewer side effects
- For research use only
Medchemexpress LLC Rapacuronium bromide | 156137-99-4 | 98.0% | 677.80 | 50 MG
Rapacuronium bromide (Org 9487) is a non-depolarizing neuromuscular blocker and an allosteric modulator of muscarinic acetylcholine receptor (mAChR).
- Acts as a non-depolarizing neuromuscular blocker
- Functions as an allosteric modulator of muscarinic acetylcholine receptor (mAChR)
- Binds to all muscarinic receptor subtypes
- Exhibits micromolar affinity and slight selectivity towards M2 receptor
- Lowers [35S]GTPγS binding to membranes
TARGETMOL CHEMICALS INC Tiotropium bromide 100MG
Also available in 1 mL, 10 mg, 25 mg, 50 mg, 500 mg and bulk. Please contact Fisher for quotes. Tiotropium bromide (BA679 BR) is a long-acting, 24 hour, anticholinergic bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). Tiotropium is a muscarinic receptor antagonist, on topical application it acts mainly on M3 muscarinic receptors located in the airways to produce smooth muscle relaxation, thus producing a bronchodilatory effect. Purity 99.09%
Medchemexpress LLC Rapacuronium bromide | 156137-99-4 | 98.0% | 677.80 | 1 ML
Rapacuronium bromide (Org 9487) is a non-depolarizing neuromuscular blocker that also acts as an allosteric modulator of the muscarinic acetylcholine receptor (mAChR). It is intended for research use only.
- Acts as a non-depolarizing neuromuscular blocker.
- Functions as an allosteric modulator of the muscarinic acetylcholine receptor (mAChR).
- Binds to all muscarinic receptor subtypes.
- Shows micromolar affinity and slight selectivity towards the M2 receptor.
- Exhibits neuromuscular effects in vivo.
Medchemexpress LLC Aclidinium Bromide | 320345-99-1 | 98.96% | C₂₆H₃₀BrNO₄S₂ | 25 MG
Aclidinium Bromide is a long-acting, inhaled muscarinic antagonist with potential for research related to chronic obstructive pulmonary disease (COPD). It shows potent antagonism of human muscarinic receptors and is rapidly hydrolyzed in human plasma.
- Potent antagonism of human muscarinic receptors
- Long residence time at M3 receptors and a shorter residence time at M2 receptors
- Suggests sustained bronchodilation
- Rapid hydrolysis in human plasma
- Low systemic bioavailability and favorable safety profile in early clinical studies
![eMolecules 10031-26-2 | Iron(III) Bromide | Accela ChemBio (ASD)295.557 | Br3Fe | 98.000 | [Fe+3].[Br-].[Br-].[Br-] | 25g | 444749735](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000162575.jpg-250.jpg)
eMolecules 10031-26-2 | Iron(III) Bromide | Accela ChemBio (ASD)295.557 | Br3Fe | 98.000 | [Fe+3].[Br-].[Br-].[Br-] | 25g | 444749735
Iron(III) Bromide | Accela ChemBio (ASD) | 10031-26-2295.557 | Br3Fe | 98.000 | [Fe+3].[Br-].[Br-].[Br-] | 25g | 444749735